DIANELYS GARCIA: Open Payments
NPI 1407103500 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 58 payments from 9 companies in 2025. Trend: 2023 $438 · 2024 $848 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $326 |
| Otsuka America Pharmaceutical, Inc. | 17 | $217 |
| Teva Pharmaceuticals USA, Inc. | 9 | $143 |
| Lundbeck LLC | 4 | $68 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
Products named: ARISTADA, REXULTI, ABILIFY ASIMTUFII, AUSTEDO XR, LYBALVI, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across NJ — which companies pay providers there.
